Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In Reply to Struikmans et al.
Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. Mutter RW, et al. Among authors: maduro jh. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1289-1290. doi: 10.1016/j.ijrobp.2021.12.155. Int J Radiat Oncol Biol Phys. 2022. PMID: 35286884 No abstract available.
Adverse late health outcomes among children treated with 3D radiotherapy techniques: Study design of the Dutch pediatric 3D-RT study.
Beijer JGM, Kok JL, Janssens GO, Streefkerk N, de Vries ACH, Slagter C, Maduro JH, Kroon PS, Grootenhuis MA, van Dulmen-den Broeder E, Loonen JJ, Wendling M, Tissing WJE, van der Pal HJ, Louwerens M, Bel A, den Hartogh J, van der Heiden-van der Loo M, Kremer LCM, Teepen JC, Ronckers CM. Beijer JGM, et al. Among authors: maduro jh. Cancer Rep (Hoboken). 2023 Feb;6(2):e1620. doi: 10.1002/cnr2.1620. Epub 2023 Jan 30. Cancer Rep (Hoboken). 2023. PMID: 36715495 Free PMC article.
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
van Kalsbeek RJ, Hudson MM, Mulder RL, Ehrhardt M, Green DM, Mulrooney DA, Hakkert J, den Hartogh J, Nijenhuis A, van Santen HM, Schouten-van Meeteren AYN, van Tinteren H, Verbruggen LC, Conklin HM, Jacola LM, Webster RT, Partanen M, Kollen WJW, Grootenhuis MA, Pieters R, Kremer LCM; International Childhood Cancer Outcome Project participants. van Kalsbeek RJ, et al. Nat Med. 2024 Feb;30(2):603. doi: 10.1038/s41591-023-02651-7. Nat Med. 2024. PMID: 37963955 No abstract available.
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.
van Hemert AKE, van Olmen JP, Boersma LJ, Maduro JH, Russell NS, Tol J, Engelhardt EG, Rutgers EJT, Vrancken Peeters MTFD, van Duijnhoven FH. van Hemert AKE, et al. Among authors: maduro jh. Breast Cancer Res Treat. 2023 May;199(1):81-89. doi: 10.1007/s10549-023-06899-y. Epub 2023 Mar 9. Breast Cancer Res Treat. 2023. PMID: 36892723
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.
Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. Mutter RW, et al. Among authors: maduro jh. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):337-359. doi: 10.1016/j.ijrobp.2021.05.110. Epub 2021 May 25. Int J Radiat Oncol Biol Phys. 2021. PMID: 34048815 Free PMC article. Review.
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer.
Choi JI, Hardy-Abeloos C, Lozano A, Hanlon A, Vargas C, Maduro JH, Bradley J, Offersen B, Haffty B, Pankuch M, Amos R, Kim N, MacDonald SM, Kirova Y, Mutter RW. Choi JI, et al. Among authors: maduro jh. Clin Transl Radiat Oncol. 2024 Aug 27;48:100847. doi: 10.1016/j.ctro.2024.100847. eCollection 2024 Sep. Clin Transl Radiat Oncol. 2024. PMID: 39280125 Free PMC article.
The prognostic value of TRAIL and its death receptors in cervical cancer.
Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG, de Bock GH, van der Zee AG. Maduro JH, et al. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):203-11. doi: 10.1016/j.ijrobp.2009.03.071. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695437
90 results